lung cancer | |||||
新闻 | |||||
Biomarker Testing in Lung Cancer: Dr. Smeltzer Unpacks Results From IASLC 2024 Survey Matthew Smeltzer, PhD, of The University of Memphis, discusses results from the 2024 International Association for the Study of Lung Cancer ...
| |||||
Researchers Begin Phase 3 Trial Assessing Adjuvant V940 With Pembrolizumab to Treat ... ... pulmonary (lung) nodule. Image credit: Saiful52 | stock.adobe.com. Lung cancer remains the leading cause of cancer death globally, with around 2.4 ...
| |||||
Ramucirumab Prolongs PFS for TKI-Naive EGFR-Mutated NSCLC Ramucirumab Added to Osimertinib Prolongs PFS for Patients With TKI-Naïve EGFR-Mutated Metastatic Non-Small Cell Lung Cancer. Stephanie Holland. 10/29 ...
| |||||
查看更多结果 | 修改此快讯 |
您收到此电子邮件是因为您订阅了Google快讯。 |
以RSS Feed的形式接收此快讯 |
发送反馈 |
No comments:
Post a Comment